Suspected drug-induced liver fatalities reported to the WHO database

Digestive and Liver Disease

Volumn 38, Issue 1, 2006, Pages 33-38

  Bjornsson E ^a   Olsson, R ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Drug therapy; Drug induced liver injury; Hepatotoxicity; Liver disease

Indexed keywords

AMIODARONE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DICLOFENAC; DIDANOSINE; FLUTAMIDE; HALOTHANE; ISONIAZID; LAMIVUDINE; METHOTREXATE; NEVIRAPINE; OXYCODONE; PARACETAMOL; PHENYTOIN; STAVUDINE; TROGLITAZONE; TROVAFLOXACIN; VALPROIC ACID; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DRUG CLASSIFICATION; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG MONITORING; EPILEPSY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; LIVER DISEASE; LIVER INJURY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PAIN; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SEX RATIO; SWEDEN; TUBERCULOSIS; UNITED STATES; WORLD HEALTH ORGANIZATION; CHEMICALLY INDUCED DISORDER; FACTUAL DATABASE; MIDDLE AGED; MORTALITY;

ANALGESICS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTICONVULSANTS; DATABASES, FACTUAL; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; WORLD HEALTH ORGANIZATION;

EID: 33645242067     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.06.004     Document Type: Article

References (38)

1. Bjørneboe M., Iversen O., and Olsen S. Infective hepatitis and toxic jaundice in a municipal hospital during a five-year period: Incidence and prognosis. Acta Med Scand 182 (1967) 491-501
2. Malchow-Møller A., Matzen P., Bjerregaard B., Hilden J., Holst-Christensen J., Staehr Johansen T., et al. Causes and characteristics of 500 consecutive causes of jaundice. Scand J Gastroenterol 16 (1981) 1-6
3. Whitehead M.W., Hainsworth I., and Kingham J.G.C. The causes of obvious jaundice in South West Wales: 2000. Gut 48 (2001) 409-413
4. Björnsson E., Ismael S., Nejdet S., and Kilander A. Severe jaundice in Sweden in the new millennium: causes, investigations, treatment and prognosis. Scand J Gastroenterol 38 (2003) 86-94
5. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al., U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
6. Wei G, Bergqvist A, Broome U, Björnsson E. Acute liver failure in Sweden: Etiology and prognosis. Scand J Gastroenterol 2004;39(Suppl. 240):36 [abstract 48].
7. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 16 (1996) 343-348
8. O'Grady J.G., Alexander G.J.M., Hayllar K.M., and Williams R. Early indicators of prognosis in fulimant hepatic failure. Gastroenterology 97 (1989) 439-445
9. Hoofnagle J.H., Carithers Jr. R.L., Shapiro C., and Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 21 (1995) 240-252
10. Bakke O.M., Manocchia M., de Abajo F., Kaitin K.I., and Lasagna L. Drug safety discontinuations in the United States, and Spain from 1974-through 1993: A regulatory perspective. Clin Pharm Ther 58 (1995) 108-117
11. Graham D.J., Green L., Senior J.R., and Nourjah P. Troglitazone-induced liver failure: a case study. Am J Med 114 (2003) 299-306
12. Watkins P.B., and Whitcomb R.W. Hepatic dysfunction associated with troglitazone. N Engl J Med 13 (1998) 916-917
13. Lee W.M. Assessing causality in drug-induced liver injury. J Hepatol 33 (2000) 1003-1005
14. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 22 (2002) 145-155
15. Aithal G.P., Rawlins M.D., and Day C.P. Accuracy of hepatic adverse drug reaction reporting in one English health region. Br Med J 319 (1999) 1541-1544
16. Danan G., and Benichou C. Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46 (1993) 1323-1330
17. Björnsson E, Jerlstad P, Bergquist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005, in press.
18. Friis H., and Andreasen P.B. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J Intern Med 232 (1992) 133-138
19. Jean-Pastor M.J., and Jouglard J. Bilan des accidents Heaptiiques medicamenteaux recueillis par la pharmacovigilance francaise. Therapie 39 (1984) 453-500
20. Pillans P.I. Drug associated hepatic reactions in New Zealand: 21 years' experience. N Z Med J 109 (1996) 315-319
21. Lee W.M. Acetaminophen and the US acute liver failure study group: lowering the risks of hepatic failure. Hepatology 40 (2004) 6-9
22. Ibanez L., Perez E., Vidal X., and Laporte J.R. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 37 (2002) 592-600
23. Helfgott S.M., Sanberg-Cook J., Zakim D., and Nestler J. Diclofenac-associated hepatotoxicity. J Am Med Assoc 10 (1990) 85-89
24. Banks A.T., Zimmerman H.J., Ishak K.G., and Harter J.G. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22 (1995) 820-827
25. Olano J.P., Borucki M.J., Wen J.W., and Haque A.K. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 21 (1995) 973-976
26. Lai K.K., Gang D.L., Zawacki J.K., and Cooley T.P. Fulminant hepatic failure associated with 2′,3′-dideoxyinosine (ddI). Ann Intern Med 115 (1991) 283-284
27. Serious adverse events attributed to nevrapine regimens for postexposure prophylaxis after HIV exposures worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep 2001;49:1153-6.
28. Hernandez L.V., Gilson I., Jacobson J., Affi A., Puetz T.R., and Dindzans V.J. Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients. Aliment Pharmacol Ther 15 (2001) 1627-1632
29. Kreisberg R. Clinical problem-solving. We blew it. N Engl J Med 332 (1995) 945-949
30. Dreifuss F.E., Santilli N., Langer D.H., Sweeney K.P., Moline K.A., and Menander K.B. Valproic acid hepatic fatalities: a retrospective review. Neurology 37 (1987) 379-385
31. Ransohoff D.F., and Jacobs G. Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology 80 (1981) 816-819
32. Alberti-Flor J.J., Hernandez M.E., Ferrer J.P., Howell S., and Jeffers L. Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. Am J Gastroenterol 84 (1989) 1577-1579
33. Ilario M.J., Ruiz J.E., and Axiotis C.A. Acute fulminant hepatic failure in a woman treated with phenytoin and trimethoprim-sulfamethoxazole. Arch Pathol Lab Med 124 (2000) 1800-1803
34. Brown S.J., and Desmond P.V. Hepatotoxicity of antimicrobial agents. Semin Liver Dis 22 (2002) 157-167
35. Schiano T.D., Lissoos T.W., Ahmed A., Siano C., Zaitman D., Cohn G., et al. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis. Am J Gastroenterol 92 (1997) 1563-1564
36. Karras A., Rabian C., Zylberberg H., Hermine O., Duchatelle V., Durand F., et al. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy. Acquir Immune Defic Syndr 12 (1998) 827-829
37. Hill J.B., Sheffield J.S., Zeeman G.G., and Wendel G.D. Hepatotoxicity with antiretroviral treatment of pregnant women. Obstet Gynecol 98 (2001) 909-911
38. Ormseth E.J., Holtzmuller K.C., Goodman Z.D., Colonna J.O., Batty D.S., and Sjogren M.H. Hepatic decompensation associated with lamivudine: a case report and review of lamivudine-induced hepatotoxicity. Am J Gastroenterol 96 (2001) 1619-1622